Mediators of pruritus in psoriasis

Mediators of Inflammation

Volumn 2007, Issue , 2007, Pages

  Reich, Adam ^a   Szepietowski, Jacek C ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CALCITONIN GENE RELATED PEPTIDE; CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HISTAMINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALFURAFINE; NALOXONE; NALTREXONE; NERVE GROWTH FACTOR; PROSTANOID; PROTEINASE ACTIVATED RECEPTOR 1; SEROTONIN; SOMATOSTATIN; VASCULAR CELL ADHESION MOLECULE 1; VASOACTIVE INTESTINAL POLYPEPTIDE; INTERLEUKIN DERIVATIVE; NARCOTIC ANALGESIC AGENT; NEUROPEPTIDE;

ANGIOGENESIS; ATOPIC DERMATITIS; HUMAN; IMMUNOREACTIVITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; PSORIASIS; PUVA; REVIEW; SKIN DISEASE; BIOLOGICAL MODEL; CELL ADHESION; CENTRAL NERVOUS SYSTEM; CHEMISTRY; GENE EXPRESSION REGULATION; INFLAMMATION; INNERVATION; METABOLISM; PATHOLOGY; SKIN;

ANALGESICS, OPIOID; CELL ADHESION; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION; HISTAMINE; HUMANS; INFLAMMATION; INTERLEUKIN-2; INTERLEUKINS; MODELS, BIOLOGICAL; NEUROPEPTIDES; PRURITUS; PSORIASIS; SKIN;

EID: 38649139315     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2007/64727     Document Type: Review

References (54)

1. J. D. Bos M. A. De Rie The pathogenesis of psoriasis: immunological facts and speculations. Immunology Today 20 1 1999 40 46
2. A. Reich J. Szepietowski Genetic and immunological aspects of the pathogenesis of psoriasis. Wiadomosci Lekarskie 60 2007 5-6 270 276
3. P. C. H. Newbold E. M. Farber A. J. Cox Pruritus in psoriasis. Proceedings of the 2nd International Symposium on Psoriasis Yorke Medical Books New York, NY, USA 1997 334 336
4. M. A. Gupta A. K. Gupta S. Kirkby Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Archives of Dermatology 124 7 1988 1052 1057
5. G. Yosipovitch gil@nsc.gov.sg A. Goon J. Wee Y. H. Chan C. L. Goh The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. British Journal of Dermatology 143 5 2000 969 973
6. J. C. Szepietowski jszepiet@derm.am.wroc.pl A. Reich B. Wiśnicka Itching in patients suffering from psoriasis. Acta Dermatovenerologica Croatica 10 4 2002 221 226
7. A. Reich J. C. Szepietowski jszepiet@derm.am.wroc.pl B. Wiśnicka P. Pacan Does stress influence itching in psoriatic patients? Dermatology and Psychosomatics 4 3 2003 151 155
8. S.-E. Chang cse@amc.seoul.kr S.-S. Han H.-J. Jung J.-H. Choi cse@amc.seoul.kr Neuropeptides and their receptors in psoriatic skin in relation to pruritus. British Journal of Dermatology 156 6 2007 1272 1277
9. A. Reich A. Orda B. Wiśnicka J. C. Szepietowski Plasma neuropeptides and perception of pruritus in psoriasis. Acta Dermato- Venereologica 87 4 2007 299 304
10. B. Wiśnicka J. C. Szepietowski jszepiet@derm.am.wroc.pl A. Reich A. Orda Histamine, substance P and calcitonin gene-related peptide plasma concentration and pruritus in patients suffering from psoriasis. Dermatology and Psychosomatics 5 2 2004 73 78
11. C. Remröd S. Lonne-Rahm K. Nordlind klas.nordlind@karolinska.se Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Archives of Dermatological Research 299 2 2007 85 91
12. A. Reich E. Hrechorow J. C. Szepietowski Negative influence of itching on psoriatic patients' well-being. Acta Dermato-Venereologica 87 2007 5 478 479
13. D. Chrostowska-Plak A. Reich J. C. Szepietowski Clinical characteristics of itching in adult patients suffering from atopic dermatitis. Acta Dermato-Venereologica 87 2007 5 477
14. J. C. Szepietowski M. Sikora M. Kusztal J. Salomon M. Magott T. Szepietowski Uremic pruritus: a clinical study of maintenance hemodialysis patients. Journal of Dermatology 29 10 2002 621 627
15. A. Dawn G. Yosipovitch Treating itch in psoriasis. Dermatology Nursing 18 3 2006 227 233
16. M. Nakamura motokazu@toyama-mpu.ac.jp M. Toyoda M. Morohashi Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. British Journal of Dermatology 149 4 2003 718 730
17. J. E. Bernstein L. C. Parish M. Rapaport M. M. Rosenbaum H. H. Roenigk Jr. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. Journal of the American Academy of Dermatology 15 3 1986 504 507
18. C. N. Ellis B. Berberian V. I. Sulica A double-blind evaluation of topical capsaicin in pruritic psoriasis. Journal of the American Academy of Dermatology 29 3 1993 438 442
19. A. Takaoka a.takaoka@po.rd.taisho.co.jp I. Arai M. Sugimoto Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Experimental Dermatology 15 3 2006 161 167
20. A. Madej A. Reich adi_medicalis@go2.pl A. Orda J. C. Szepietowski Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients. Journal of the European Academy of Dermatology and Venereology 21 1 2007 72 78
21. J. L. Hundley G. Yosipovitch gyosipov@wfubmc.edu Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. Journal of the American Academy of Dermatology 50 6 2004 889 891
22. M. Bigliardi-Qi B. Lipp L. T. Sumanovski S. A. Buechner P. L. Bigliardi paul.bigliardi@kssh.ch Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 210 2 2005 91 99
23. M. Tominaga H. Ogawa K. Takamori ktakamor@med.juntendo.ac.jp Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. Journal of Investigative Dermatology 127 9 2007 2228 2235
24. G. Heyer M. Dotzer T. L. Diepgen H. O. Handwerker Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis. Pain 73 2 1997 239 243
25. G. Heyer gisela.heyer@derma.med.uni-erlangen.de D. Groene P. Martus Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema. Experimental Dermatology 11 5 2002 448 455
26. K. Takamori H. Kumagai T. Ebata T. Muramatsu H. Nakamoto H. Suzuki Confirmatory study of Trk-820, kappa opioid agonist, against pruritus resistant to the currently available treatment in hemodialysis patients. Acta Dermato-Venereologica 87 2007 5 465
27. H. Umeuchi Y. Kawashima K. Kikuchi Possibility for new antipruritic agent, nalfurafine hydrochloride (Trk-820), in primary billiary cirrhosis. Acta Dermato-Venereologica 87 2007 5 465
28. M. Sugimoto masanori.sugimoto@po.rd.taisho.co.jp I. Arai N. Futaki Y. Hashimoto Y. Honma S. Nakaike Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D 2 biosynthesis in NC/Nga mice with atopic dermatitis. Experimental Dermatology 14 12 2005 898 905
29. A. Takaoka a.takaoka@po.rd.taisho.co.jp I. Arai M. Sugimoto Role of scratch-induced cutaneous prostaglandin D 2 production on atopic-like scratching behaviour in mice. Experimental Dermatology 16 4 2007 331 339
30. M. Steinhoff msteinho@uni-muenster.de J. Bienenstock M. Schmelz M. Maurer E. Wei T. Bíró Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. Journal of Investigative Dermatology 126 8 2006 1705 1718
31. M. Steinhoff U. Neisius A. Ikoma Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. Journal of Neuroscience 23 15 2003 6176 6180
32. H. Ui T. Andoh J.-B. Lee H. Nojima Y. Kuraishi kuraisiy@ms.toyama-mpu.ac. jp Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. European Journal of Pharmacology 530 1-2 2006 172 178
33. S. G. Shimada steven.shimada@yale.edu K. A. Shimada J. G. Collins Scratching behavior in mice induced by the proteinase-activated receptor-2 agonist, SLIGRL-NH 2. European Journal of Pharmacology 530 3 2006 281 283
34. S. Ständer sonja.staender@uni-muenster.de M. Steinhoff Pathophysiology of pruritus in atopic dermatitis: an overview. Experimental Dermatology 11 1 2002 12 24
35. P. Arck petra.arck@charite.de R. Paus From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. NeuroImmunoModulation 13 5-6 2007 347 356
36. D. J. Eedy C. F. Johnston C. Shaw K. D. Buchanan Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. Journal of Investigative Dermatology 96 4 1991 434 438
37. A. Naukkarinen I. Harvima K. Paukkonen M.-L. Aaltol M. Horsmanheimo Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Archives of Dermatological Research 285 6 1993 341 346
38. J. Chan B. R. Smoller S. P. Raychauduri W.-Y. Jiang E. M. Farber Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Archives of Dermatological Research 289 11 1997 611 616
39. W.-Y. Jiang S. P. Raychaudhuri E. M. Farber Double-labeled immunofluorescence study of cutaneous nerves in psoriasis. International Journal of Dermatology 37 8 1998 572 574
40. S. P. Raychaudhuri W.-Y. Jiang E. M. Farber Psoriatic keratinocytes express high levels of nerve growth factor. Acta Dermato-Venereologica 78 2 1998 84 86
41. V. Staniek J.-D. Doutremepuich D. Schmitt A. Claudy L. Misery Laurent.Misery@univ-st-etienne.fr Expression of substance P receptors in normal and psoriatic skin. Pathobiology 67 1 1999 51 54
42. M. Steinhoff mstein1@itsa.ucsf.edu G. P. McGregor A. Radleff-Schlimme A. Steinhoff H. Jarry W. E. Schmidt Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis. Regulatory Peptides 80 1-2 1999 49 55
43. Y. He G. Ding X. Wang T. Zhu S. Fan Calcitonin gene-related peptide in Langerhans cells in psoriatic plaque lesions. Chinese Medical Journal 113 8 2000 747 751
44. A. Reich adi_medicalis@go2.pl A. Orda B. Wiśnicka J. C. Szepietowski Plasma concentration of selected neuropeptides in patients suffering from psoriasis. Experimental Dermatology 16 5 2007 421 428
45. A. Naukkarinen I. T. Harvima M.-L. Aalto M. Horsmanheimo Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. International Journal of Dermatology 33 5 1994 361 366
46. J. Huskic F. Alendar A. Matavulj L. Ostoic Serum angiotensin converting enzyme in patients with psoriasis. Medicinski Arhiv 58 4 2004 202 205
47. T. Andoh Y. Nishikawa T. Yamaguchi-Miyamoto H. Nojima S. Narumiya Y. Kuraishi kuraisiy@pha.u-toyama.ac.jp Thromboxane A 2 induces itch-associated responses through TP receptors in the skin in mice. Journal of Investigative Dermatology 127 8 2007 2042 2047
48. T. Yamaguchi T. Nagasawa M. Satoh Y. Kuraishi kuraisiy@ms.toyama-mpu.ac. jp Itch-associated response induced by intradermal serotonin through 5- HT 2 receptors in mice. Neuroscience Research 35 2 1999 77 83
49. R. Paus ralf.paus@uk-sh.de M. Schmelz T. Bíró M. Steinhoff Frontiers in pruritus research: scratching the brain for more effective itch therapy. Journal of Clinical Investigation 116 5 2006 1174 1185
50. U. Darsow A. Drzezga M. Frisch Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. Journal of Investigative Dermatology 115 6 2000 1029 1033
51. J.-C. Hsieh O. Hägermark M. Ståhle-Backdahl Urge to scratch represented in the human cerebral cortex during itch. Journal of Neurophysiology 72 6 1994 3004 3008
52. B. Walter M. N. Sadlo J. Kupfer Brain activation by histamine prick test-induced itch. Journal of Investigative Dermatology 125 2 2005 380 382
53. Y. Ishiuji T. Patel R. C. Coghill The activation of brain networks during scratching. Acta Dermato-Venereologica 87 2007 5 475 476
54. Y. Ishiuji R. C. Coghill T. Patel R. A. Kraft Y. Oshiro G. Yosipovitch The brain processing of pruritus in atopic dermatitis. Acta Dermato- Venereologica 87 2007 5 476